Wagstaff KM et al., 2012-05-01: Biochemical characterisation establishing ivermectin as a specific, broad-spectrum inhibitor of importin alpha/beta-mediated nuclear import, with no effect on other import pathways, and showing antiviral activity against HIV-1 and dengue virus.
In the present study, we characterized in detail the nuclear transport inhibitory properties of ivermectin, demonstrating that it is a broad-spectrum inhibitor of importin α/β nuclear import, with no effect on a range of other nuclear import pathways, including that mediated by importin β1 alone.
n/a (PubMed abstract)
Wagstaff KM et al., 2012-05-01: Biochemical characterisation establishing ivermectin as a specific, broad-spectrum inhibitor of importin alpha/beta-mediated nuclear import, with no effect on other import pathways, and showing antiviral activity against HIV-1 and dengue virus. Study type: cell-based nuclear import assays with recombinant importin systems plus viral replication assays. N: n/a. Country: Australia (Monash University, Melbourne). Dose: in vitro, not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: other nuclear import pathways (importin beta1 alone). This is the founding paper for the importin alpha/beta target that underpins the anticancer nuclear-transport work; it is not itself a cancer study. Study type: lab.
